The effect of ephrin-A1 on resistance to Photofrin-mediated photodynamic therapy in esophageal squamous cell carcinoma cells

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Lasers in Medical Science

• Publication date

  2015-10-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10103-015-1812-8PMID 26450615
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lack of Ephrin Receptor A1 Is a Favorable Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma

  2014cited by this paper
• ADAM12-cleaved ephrin-A1 contributes to lung metastasis

  2014cited by this paper
• The effects of Photofrin-mediated photodynamic therapy on the modulation of EGFR in esophageal squamous cell carcinoma cells

  2013cited by this paper
• Ephs and ephrins in cancer: ephrin-A1 signalling.

  2012cited by this paper
• Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene

  2012cited by this paper
• The Ephrin A1–EphA2 System Promotes Cardiac Stem Cell Migration After Infarction

  2011cited by this paper
• Ephrin-A1 Regulates Cell Remodeling and Migration

  2011cited by this paper
• Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy.

  2011cited by this paper
• Alcohol drinking and esophageal squamous cell carcinoma with focus on light‐drinkers and never‐smokers: A systematic review and meta‐analysis

  2011cited by this paper
• TNF-α-induced ROS production triggering apoptosis is directly linked to Romo1 and Bcl-XL

  2010cited by this paper
• Ephrins and Eph receptors in stem cells and cancer.

  2010cited by this paper
• Soluble ephrin a1 is necessary for the growth of HeLa and SK-BR3 cells

  2010cited by this paper
• Over-Expression of EphA2 and EphrinA-1 in Human Gastric Adenocarcinoma and Its Prognostic Value for Postoperative Patients

  2009cited by this paper
• Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer.

  2009cited by this paper
• Nonoperable Patients With Superficial Esophageal Cancer Treated by Photodynamic Therapy After Chemoradiotherapy Have More Severe Complications Than Patients Treated in Primary Intent

  2008cited by this paper
• Ephrin-A1 promotes the malignant progression of intestinal tumors in Apcmin/+ mice

  2008cited by this paper
• Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor

  2008cited by this paper
• The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting

  2008cited by this paper
• Photodynamic therapy of early esophageal cancer.

  2008cited by this paper
• Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.

  2007cited by this paper
• Outcome of photodynamic therapy for early esophageal cancer.

  2007cited by this paper
• Expression of EphA2 and Ephrin A-1 in Carcinoma of the Urinary Bladder

  2006cited by this paper
• Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.

  2006cited by this paper
• The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.

  2005cited by this paper
• Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma.

  2005cited by this paper
• Ephrin-A1 expression contributes to the malignant characteristics of α-fetoprotein producing hepatocellular carcinoma

  2005cited by this paper
• Keratinocyte‐derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts

  2004cited by this paper
• PROGNOSTIC VALUE OF EPHA2 AND EPHRINA-1 IN SQUAMOUS CELL CERVICAL CARCINOMA

  2004cited by this paper
• The role of ephrins and Eph receptors in cancer.

  2004cited by this paper
• Regulation of proliferation, survival and apoptosis by members of the TNF superfamily.

  2003cited by this paper
• Esophageal cancer.

  2003cited by this paper
• Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.

  2003cited by this paper
• Tumor Necrosis Factor-α Induction of Endothelial Ephrin A1 Expression Is Mediated by a p38 MAPK- and SAPK/JNK-dependent but Nuclear Factor-κB-independent Mechanism*

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Increased cytotoxic effects of photodynamic therapy in IL‐6 gene transfected cells via enhanced apoptosis

  2001cited by this paper
• Tumor necrosis factor-alpha induction of endothelial ephrin A1 expression is mediated by a p38 MAPK- and SAPK/JNK-dependent but nuclear factor-kappa B-independent mechanism.

  2001cited by this paper
• In Vitro Induction of PDT Resistance in HT29, HT1376 and SK‐N‐MC Cells by Various Photosensitizers ¶

  2001cited by this paper
• Risk of betel chewing for oesophageal cancer in Taiwan

  2001cited by this paper
• In Vitro Induction of PDT Resistance in HT29, HT1376 and SK-N-MC Cells by Various Photosensitizers¶

  2001cited by this paper
• Up‐regulation of ephrin‐a1 during melanoma progression

  1999cited by this paper
• DNA damage induced by tumour necrosis factor-alpha in L929 cells is mediated by mitochondrial oxygen radical formation.

  1995cited by this paper
• Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity.

  1994cited by this paper
• HOW DOES PHOTODYNAMIC THERAPY WORK?

  1992cited by this paper
• RESISTANCE TO PHOTODYNAMIC THERAPY IN RADIATION INDUCED FIBROSARCOMA‐1 and CHINESE HAMSTER OVARY‐MULTI‐DRUG RESISTANT CELLS in vitro

  1991cited by this paper
• Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factors-α

  1991cited by this paper
• Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-alpha.

  1991cited by this paper
• Photodynamic Therapy

  1988cited by this paper
• Biologic properties of three newly established human esophageal carcinoma cell lines.

  1984influential reference
• the Harwood Academic Publishers imprint, part of The Gordon and Breach Publishing Group. Printed in Malaysia. Photodynamic Therapy for 101 Early Cancers of the Upper Aerodigestive Tract, the Esophagus, and the Bronchi: A Single-Institution Experience

  year unknowncited by this paper

• Algorithm for Barrett’s esophagus diagnosis based on the magnifying chromoendoscopy results

  2022cites this paper
• Effects of EFNA1 on cell phenotype and prognosis of esophageal carcinoma

  2021cites this paper
• EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma

  2021cites this paper
• Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axis.

  2021cites this paper
• Role of EFNA1 in tumorigenesis and prospects for cancer therapy.

  2020cites this paper
• The miR-1224-5p/TNS4/EGFR axis inhibits tumour progression in oesophageal squamous cell carcinoma

  2020cites this paper
• Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)

  2019cites this paper
• Circulating Interleukin-6 is Associated with Prognosis and Genetic Polymorphisms of MIR608 in Patients with Esophageal Squamous Cell Carcinoma

  2018cites this paper
• The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma

  2016cites this paper
• Translational research in thoracic surgery-the National Taiwan University Hospital experience.

  2016cites this paper